Compare VSME & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | VSME | ITOC |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | Hong Kong | China |
| Employees | N/A | 7 |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0M | 5.6M |
| IPO Year | 2022 | N/A |
| Metric | VSME | ITOC |
|---|---|---|
| Price | $1.65 | $0.31 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 10.3M | 307.7K |
| Earning Date | 10-31-2025 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.07 | $0.25 |
| 52 Week High | $5.38 | $1.15 |
| Indicator | VSME | ITOC |
|---|---|---|
| Relative Strength Index (RSI) | 49.30 | 48.88 |
| Support Level | $0.88 | $0.28 |
| Resistance Level | $1.88 | $0.34 |
| Average True Range (ATR) | 0.35 | 0.03 |
| MACD | -0.08 | -0.00 |
| Stochastic Oscillator | 6.88 | 24.86 |
VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: marketing services and social commerce. The firm generates almost all of its revenue from marketing services, which reflects the company's business of marketing services to clients and social media platforms. The social commerce segment reflects the company's business of social commerce with customers. Geographically, the firm generates revenue from the HK SAR and Taiwan.
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors. Its product portfolio also includes Medical Auxiliary Supplies such as seed implant needles, computer workstations, patient positioning device, etc.